Trade Summary

4 days ago, Patel Jeegar Pravinkumar, serving as Chief Scientific Officer at Evommune, Inc. (EVMN), sold 16,687 shares at $22.74 per share, for a total transaction value of $379,462.38. Following this transaction, Patel Jeegar Pravinkumar now holds 46,403 shares of EVMN.

This sale represents a 26.45% decrease in Patel Jeegar Pravinkumar's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 1, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 (accepted Jun 3, 8:02 PM ET), 3 days after the trade was made.